McCormick & Company, Incorporated (MKC) Is Playing Well With Weight Loss Drugs, Says Jim Cramer

McCormick & Company, Incorporated (NYSE:MKC) is one of the Jim Cramer Warns Viewers About FOMO & Discusses These 19 Stocks.

McCormick & Company, Incorporated (NYSE:MKC) is one of America’s largest spice companies. While food stocks have faced a bloodbath in 2025 as inflation and GLP-1 drugs cut into their revenue, McCormick & Company, Incorporated (NYSE:MKC)’s shares have fared well as they are flat year-to-date. McCormick & Company, Incorporated (NYSE:MKC)’s stock jumped by 5% in June after the firm’s fiscal Q2 earnings of $0.69 beat analyst estimates of $0.66 and its revenue met the estimates. The low-end of its full year earnings guidance of $3.03 per share also beat estimates of $3.02.  Cramer explained that the results saw food investors rush to a stock they thought could do well:

“Okay, McKornick is up four dollars. Now Brendan Foley runs the company, it’s not MCK, it’s MKC. Now here’s what important about this. I haven’t seen a food company guide up and they did. Why? Okay, spices are not anything that has to do with GLP-1, they don’t put weight, they don’t put weight. So think about this, mustard doesn’t put weight. It’s one of the few foods that doesn’t. Spices, way to be able to make something better, not fattening. They are fitting with the GLP-1 zeitgeist. And that’s why the stock is up three.

“What happens is David, people who cover the food group, they say oh my god I got one good, I got one good, and they will push Brendan Foley, this stock will go up another, I think it will go to, to 52-week high of 85.

“Look I don’t own any of these stocks for my charitable trust. I don’t have any of these for my charitable trust.”

McCormick & Company, Incorporated (MKC) Is Playing Well With Weight Loss Drugs, Says Jim Cramer

A close-up of spices, herbs and seasoning mixes in a colorful array, highlighting the company’s range of products.

Cramer discussed McCormick & Company, Incorporated (NYSE:MKC) in detail in March. Here is what he said:

“And I just wanted to defend McKormick for a second, now they do have two percent volume growth. It’s not bad. They do have some currency that really knocked things down. People are not factoring it. If you factored in the currency which was bigger than they thought, it’s actually in-line. But what I like about McKormick best, is that people are, when people are . . .and don’t want to go out to expensive restaurants, they cook. And when you cook, you use spice. . .And McCormick is a spice company, and I think they’re gonna do very well if things get, uh, let’s say tougher in the country. Because do it yourself does well. And cooking does well. And McCormick will do well.”

“I like to look at the future. And Brendan Foley I think is going to do a good job. I think that, they talk about, look they talk about Europe being very strong. Which does matter. And they just talk about, listen you gotta recognize that, you have to recognize the behavior of people. And, there are a lot of people. . .who think there’s a slowdown. And they’re very very concerned. And they’re cooking at home.”

“And I’m just saying, don’t give up on it. Because, if you think that we’re having a slowdown, people are going to cook at home. You were gonna wish you were in it.”

“And I don’t think that’s wrong, because the restaurant costs so much unless you go to Longhorn’s, you know well Longhorn’s cheaper . . .or you go to Texas Roadhouse, or you go, Cracker Barrel’s. . .but I just think that, people aren’t, KB Homes, that was a big cut price in their homes. First time.”

While we acknowledge the potential of MKC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.